CIHR New Investigator Grant in Maternal, Reproductive, Child and Youth Health
2018: Awarded to Dr. Rayzel Shulman in partnership with the Institute of Nutrition, Metabolism and Diabetes for "Bridging the gap to prevent adverse events between pediatric and adult diabetes care."
CIHR New Investigator Grant in Maternal, Reproductive, Child and Youth Health
2018: Awarded to Dr. Hilary Brown in partnership with the Institute of Human Development, Child and Youth Health for "Infants born to women with disabilities: health and healthcare."
Shirley A. Brown Memorial Chair in Women’s Mental Health Research
2018: Dr. Simone Vigod appointed for a five year term. The chair is based at Women’s College Hospital (WCH), in collaboration with the Centre for Addiction and Mental Health (CAMH) at the University of Toronto.
Clarivate Analytics Highly Cited Researchers 2017
2017: Dr. Peter Austin was selected by Clarivate Analytics as one the most highly cited researchers of 2017. This annual list identifies researchers who have published a high number of papers that rank within the top 1% of most-cited works in their field during its year of publication.
Maurice Wood Award for Lifetime Contribution to Primary Care Research
2017: Awarded to Dr. Moira Stewart by the North American Primary Care Research Group. Read more.
ESMO Young investigator Travel Award
2017: Awarded to Dr. Jacques Raphael for the paper "Palbociclib in hormone receptor positive advanced breast cancer: a cost-utility analysis."
Health System Impact Fellowship
2017-2019: Awarded to Dr. Morgan Slater by the Canadian Institutes of Health Research for the project "Managing chronic pain in primary care – linking clinical and administrative data to identify opportunities for quality improvement."
Fellow, American Society of Addiction Medicine
2017: Dr. David Marsh inducted Fellow, American Society of Addiction Medicine.
Global Cardio-Oncology Summit Young Investigator Award
2017: Presented to Dr. Husam Abdel-Qadir by the Canadian Cardiac Oncology Network for "A score to predict cardiovascular disease risk after early stage breast cancer."